New drug combo aims to fight Hard-to-Treat lymphoma
Disease control
Recruiting now
This study is for adults with mantle cell lymphoma, a type of blood cancer. Researchers are testing a combination of two drugs, zanubrutinib and tafasitamab, to find the safest and most effective dose. The goal is to see if the combination can shrink or eliminate tumors. About 27…
Phase: PHASE1, PHASE2 • Sponsor: Alvaro Alencar, MD • Aim: Disease control
Last updated May 26, 2026 11:31 UTC